September 07, 2025 a 07:43 am
ELV: Fundamental Ratio Analysis - Elevance Health Inc.
Elevance Health Inc., previously known as Anthem, Inc., demonstrates a strong market presence in the health benefits arena. With its extensive reach affecting around 118 million people, the company's diverse portfolio of medical and digital solutions showcases robust industry positioning, yet faces competition within its sector.
Fundamental Rating
Elevance Health Inc.'s overall fundamental rating is 'B+'. The company exhibits strong financials in several areas.
| Category | Score | Score Bar |
|---|---|---|
| Discounted Cash Flow (DCF) | 5 | |
| Return on Equity (ROE) | 4 | |
| Return on Assets (ROA) | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings (P/E) | 2 | |
| Price to Book (P/B) | 3 |
Historical Rating
Examining the historical data, the current scores resonate with past performance indicators.
| Date | Overall | DCF | ROE | ROA | Debt/Eq | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-09-05 | 3 | 5 | 4 | 4 | 1 | 2 | 3 |
| -- | 0 | 5 | 4 | 4 | 1 | 2 | 3 |
Analyst Price Targets
Analyst projections show confidence with a stable outlook, reflecting well in consensus pricing.
| High | Low | Median | Consensus |
|---|---|---|---|
| $500 | $465 | $482.5 | $482.5 |
Analyst Sentiment
Current analyst sentiment is supportive with predominant buying recommendations.
| Recommendation | Count | Distribution Bar |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 28 | |
| Hold | 9 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Elevance Health Inc. presents as a robust contender in the healthcare sector with a commendable set of fundamental scores and positive analyst sentiment. While there are challenges such as debt management and market volatility, the company’s track record and continuous name recognition promise potential future gains for investors. Strong buy recommendations from analysts emphasize confidence in Elevance Health’s strategic market positioning.